Francesca Sperotto, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dexmedetomidine | 8 | 2023 | 315 | 2.690 |
Why?
|
Cardiopulmonary Resuscitation | 5 | 2024 | 974 | 2.130 |
Why?
|
Intensive Care Units, Pediatric | 11 | 2023 | 979 | 1.420 |
Why?
|
Heart Arrest | 3 | 2023 | 1469 | 1.270 |
Why?
|
Puberty | 3 | 2015 | 489 | 1.150 |
Why?
|
Substance Withdrawal Syndrome | 4 | 2023 | 633 | 1.020 |
Why?
|
Heart Defects, Congenital | 5 | 2023 | 4566 | 0.930 |
Why?
|
Hypnotics and Sedatives | 9 | 2023 | 1158 | 0.850 |
Why?
|
Extracorporeal Membrane Oxygenation | 3 | 2022 | 1348 | 0.850 |
Why?
|
Delirium | 3 | 2023 | 1608 | 0.810 |
Why?
|
Osteosclerosis | 2 | 2020 | 39 | 0.810 |
Why?
|
Hypoplastic Left Heart Syndrome | 2 | 2023 | 568 | 0.800 |
Why?
|
Scleroderma, Localized | 3 | 2021 | 79 | 0.790 |
Why?
|
Morphine | 1 | 2023 | 657 | 0.660 |
Why?
|
Joint Instability | 3 | 2017 | 792 | 0.660 |
Why?
|
Heart Diseases | 2 | 2023 | 2789 | 0.660 |
Why?
|
Child | 43 | 2024 | 77478 | 0.660 |
Why?
|
Wilms Tumor | 2 | 2020 | 368 | 0.650 |
Why?
|
Deep Sedation | 1 | 2018 | 121 | 0.590 |
Why?
|
Propofol | 1 | 2023 | 628 | 0.580 |
Why?
|
Bone Diseases, Developmental | 1 | 2017 | 130 | 0.580 |
Why?
|
Critical Illness | 6 | 2023 | 2665 | 0.560 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2020 | 609 | 0.510 |
Why?
|
Scleroderma, Systemic | 2 | 2021 | 313 | 0.500 |
Why?
|
Postoperative Care | 1 | 2021 | 1484 | 0.490 |
Why?
|
Analgesia | 3 | 2023 | 459 | 0.450 |
Why?
|
Cardiology | 1 | 2024 | 1658 | 0.430 |
Why?
|
Antibodies, Antinuclear | 1 | 2014 | 326 | 0.430 |
Why?
|
Anesthesia | 2 | 2020 | 1548 | 0.420 |
Why?
|
Critical Care | 3 | 2023 | 2640 | 0.420 |
Why?
|
Joints | 1 | 2013 | 326 | 0.410 |
Why?
|
Intensive Care Units | 7 | 2023 | 3679 | 0.390 |
Why?
|
Palliative Care | 3 | 2023 | 3478 | 0.380 |
Why?
|
Italy | 4 | 2022 | 828 | 0.350 |
Why?
|
Surgical Procedures, Operative | 1 | 2021 | 1873 | 0.340 |
Why?
|
Tumor Suppressor Proteins | 2 | 2020 | 2842 | 0.320 |
Why?
|
Retrospective Studies | 22 | 2023 | 77098 | 0.320 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2020 | 2915 | 0.310 |
Why?
|
Musculoskeletal Diseases | 1 | 2013 | 581 | 0.300 |
Why?
|
Quality Improvement | 1 | 2021 | 3738 | 0.270 |
Why?
|
Hospitalization | 4 | 2022 | 10232 | 0.270 |
Why?
|
Infant, Newborn | 9 | 2023 | 25575 | 0.260 |
Why?
|
Humans | 53 | 2024 | 742088 | 0.260 |
Why?
|
Pulmonary Artery | 2 | 2023 | 1911 | 0.250 |
Why?
|
Pandemics | 3 | 2022 | 8328 | 0.250 |
Why?
|
Atrial Fibrillation | 1 | 2022 | 5019 | 0.230 |
Why?
|
Respiration, Artificial | 3 | 2023 | 2566 | 0.230 |
Why?
|
Benzodiazepines | 4 | 2023 | 1101 | 0.220 |
Why?
|
Erythroblasts | 1 | 2023 | 150 | 0.220 |
Why?
|
Ductus Arteriosus, Patent | 1 | 2023 | 209 | 0.210 |
Why?
|
Infant | 10 | 2023 | 35070 | 0.200 |
Why?
|
Norwood Procedures | 1 | 2023 | 182 | 0.200 |
Why?
|
Aortic Coarctation | 1 | 2023 | 281 | 0.200 |
Why?
|
Europe | 3 | 2023 | 3339 | 0.200 |
Why?
|
Neuromuscular Blocking Agents | 1 | 2022 | 130 | 0.190 |
Why?
|
Iatrogenic Disease | 1 | 2023 | 545 | 0.180 |
Why?
|
Methotrexate | 2 | 2019 | 1720 | 0.180 |
Why?
|
Catheter-Related Infections | 1 | 2022 | 252 | 0.170 |
Why?
|
Adrenergic alpha-2 Receptor Agonists | 1 | 2019 | 87 | 0.170 |
Why?
|
Postoperative Complications | 1 | 2021 | 15244 | 0.170 |
Why?
|
Analgesics, Opioid | 4 | 2023 | 3667 | 0.160 |
Why?
|
Endocarditis, Bacterial | 1 | 2023 | 453 | 0.160 |
Why?
|
Endocarditis | 1 | 2023 | 348 | 0.160 |
Why?
|
Treatment Outcome | 9 | 2023 | 62966 | 0.160 |
Why?
|
Child, Preschool | 8 | 2023 | 40955 | 0.150 |
Why?
|
Vena Cava, Inferior | 1 | 2021 | 436 | 0.150 |
Why?
|
Catheterization, Central Venous | 1 | 2022 | 514 | 0.150 |
Why?
|
Off-Label Use | 1 | 2018 | 169 | 0.150 |
Why?
|
Cardiopulmonary Bypass | 1 | 2022 | 1066 | 0.150 |
Why?
|
Postoperative Period | 1 | 2022 | 1839 | 0.150 |
Why?
|
Ketamine | 1 | 2022 | 499 | 0.140 |
Why?
|
Potassium | 1 | 2021 | 1336 | 0.140 |
Why?
|
Positive-Pressure Respiration | 1 | 2021 | 632 | 0.140 |
Why?
|
Analgesics | 1 | 2023 | 1037 | 0.140 |
Why?
|
Adolescent | 13 | 2022 | 85649 | 0.140 |
Why?
|
Pulmonary Valve | 1 | 2020 | 437 | 0.140 |
Why?
|
Urinary Tract Infections | 1 | 2022 | 786 | 0.130 |
Why?
|
Phototherapy | 1 | 2019 | 377 | 0.130 |
Why?
|
Bacteremia | 1 | 2022 | 962 | 0.130 |
Why?
|
Heart Ventricles | 2 | 2023 | 3801 | 0.120 |
Why?
|
Prednisone | 1 | 2019 | 1567 | 0.120 |
Why?
|
Myocarditis | 1 | 2021 | 770 | 0.120 |
Why?
|
Shock, Septic | 1 | 2020 | 773 | 0.120 |
Why?
|
Drug Interactions | 1 | 2018 | 1458 | 0.120 |
Why?
|
Feasibility Studies | 1 | 2023 | 5062 | 0.120 |
Why?
|
Bacterial Infections | 1 | 2022 | 1389 | 0.110 |
Why?
|
Germ-Line Mutation | 2 | 2020 | 1786 | 0.110 |
Why?
|
Arrhythmias, Cardiac | 1 | 2023 | 2267 | 0.110 |
Why?
|
Skull | 1 | 2017 | 810 | 0.110 |
Why?
|
Hospital Mortality | 2 | 2023 | 5310 | 0.100 |
Why?
|
Hemodynamics | 2 | 2022 | 4197 | 0.100 |
Why?
|
Growth | 1 | 2013 | 376 | 0.100 |
Why?
|
Heart Valve Prosthesis | 1 | 2020 | 1486 | 0.100 |
Why?
|
Obesity | 1 | 2013 | 12705 | 0.100 |
Why?
|
Drug Resistance, Microbial | 1 | 2014 | 860 | 0.090 |
Why?
|
Sex Factors | 2 | 2015 | 10392 | 0.090 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2020 | 1527 | 0.090 |
Why?
|
Prospective Studies | 4 | 2022 | 53187 | 0.090 |
Why?
|
Hospitals | 1 | 2023 | 3937 | 0.080 |
Why?
|
Female | 14 | 2022 | 379592 | 0.080 |
Why?
|
Longitudinal Studies | 2 | 2015 | 13921 | 0.080 |
Why?
|
Early Diagnosis | 1 | 2013 | 1184 | 0.080 |
Why?
|
Cross-Sectional Studies | 2 | 2023 | 24913 | 0.080 |
Why?
|
Male | 13 | 2022 | 349538 | 0.080 |
Why?
|
Pediatrics | 1 | 2023 | 3462 | 0.080 |
Why?
|
Hematologic Neoplasms | 1 | 2019 | 1820 | 0.080 |
Why?
|
Prevalence | 2 | 2015 | 15194 | 0.070 |
Why?
|
Risk Factors | 4 | 2021 | 72145 | 0.070 |
Why?
|
Chi-Square Distribution | 1 | 2013 | 3510 | 0.070 |
Why?
|
Consensus | 3 | 2021 | 2935 | 0.070 |
Why?
|
Survival Rate | 1 | 2021 | 12773 | 0.070 |
Why?
|
Radiography | 1 | 2017 | 7010 | 0.070 |
Why?
|
Sepsis | 1 | 2020 | 2589 | 0.070 |
Why?
|
United States | 3 | 2023 | 69693 | 0.070 |
Why?
|
Cardiac Surgical Procedures | 1 | 2021 | 3526 | 0.070 |
Why?
|
Opioid-Related Disorders | 1 | 2019 | 2062 | 0.060 |
Why?
|
Aorta | 2 | 2023 | 2057 | 0.060 |
Why?
|
Activities of Daily Living | 1 | 2013 | 2414 | 0.060 |
Why?
|
Pain Measurement | 1 | 2013 | 3418 | 0.060 |
Why?
|
Phenotype | 1 | 2020 | 16331 | 0.050 |
Why?
|
Incidence | 1 | 2021 | 20928 | 0.050 |
Why?
|
Blood Cell Count | 1 | 2023 | 402 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7276 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2021 | 39004 | 0.050 |
Why?
|
Dentists | 1 | 2023 | 169 | 0.050 |
Why?
|
Drug Administration Schedule | 2 | 2019 | 4929 | 0.050 |
Why?
|
Central Venous Pressure | 1 | 2021 | 78 | 0.050 |
Why?
|
Cohort Studies | 3 | 2022 | 40450 | 0.050 |
Why?
|
Intensive Care, Neonatal | 1 | 2022 | 197 | 0.050 |
Why?
|
Immunosuppressive Agents | 1 | 2013 | 4147 | 0.050 |
Why?
|
Cardiac Imaging Techniques | 1 | 2021 | 269 | 0.040 |
Why?
|
Logistic Models | 1 | 2013 | 13403 | 0.040 |
Why?
|
Multiple Organ Failure | 1 | 2020 | 389 | 0.040 |
Why?
|
Drug Tolerance | 1 | 2019 | 375 | 0.040 |
Why?
|
Evidence-Based Medicine | 2 | 2021 | 3611 | 0.040 |
Why?
|
Boston | 2 | 2021 | 9305 | 0.040 |
Why?
|
Troponin | 1 | 2021 | 524 | 0.040 |
Why?
|
Antibiotic Prophylaxis | 1 | 2023 | 638 | 0.040 |
Why?
|
Aorta, Thoracic | 1 | 2023 | 1080 | 0.040 |
Why?
|
Body Mass Index | 1 | 2015 | 12695 | 0.040 |
Why?
|
Pain | 2 | 2023 | 4961 | 0.040 |
Why?
|
Perfusion | 1 | 2021 | 1359 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2021 | 57683 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2014 | 7153 | 0.030 |
Why?
|
Propensity Score | 1 | 2022 | 1771 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2019 | 2271 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2019 | 1661 | 0.030 |
Why?
|
Fever | 1 | 2022 | 1612 | 0.030 |
Why?
|
Prosthesis Design | 1 | 2020 | 2110 | 0.030 |
Why?
|
Uveitis | 1 | 2017 | 375 | 0.030 |
Why?
|
Guideline Adherence | 1 | 2023 | 2266 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15530 | 0.030 |
Why?
|
Administration, Oral | 1 | 2019 | 3913 | 0.020 |
Why?
|
Survivors | 1 | 2020 | 2286 | 0.020 |
Why?
|
Adult | 2 | 2021 | 213712 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2021 | 3656 | 0.020 |
Why?
|
Echocardiography | 1 | 2021 | 5097 | 0.020 |
Why?
|
Stroke Volume | 1 | 2021 | 4983 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6483 | 0.020 |
Why?
|
Mental Health | 1 | 2022 | 2997 | 0.020 |
Why?
|
Length of Stay | 1 | 2021 | 6294 | 0.020 |
Why?
|
Heart | 1 | 2021 | 4462 | 0.020 |
Why?
|
Electrocardiography | 1 | 2021 | 6440 | 0.020 |
Why?
|
Disease Management | 1 | 2019 | 2450 | 0.020 |
Why?
|
Communication | 1 | 2022 | 3728 | 0.020 |
Why?
|
Patient Discharge | 1 | 2020 | 3300 | 0.020 |
Why?
|
Ultrasonography | 1 | 2021 | 5978 | 0.020 |
Why?
|
Parents | 1 | 2020 | 3387 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8621 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2019 | 10943 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2019 | 12017 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2023 | 19862 | 0.020 |
Why?
|
Young Adult | 2 | 2020 | 56350 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 9941 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18355 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2022 | 7645 | 0.010 |
Why?
|
Prognosis | 1 | 2019 | 29010 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 40054 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 35342 | 0.010 |
Why?
|
Aged | 1 | 2023 | 162944 | 0.010 |
Why?
|